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Abstract 
Background and Aim: Coronary ectasia is one of the prevalent cardiovascular diseases worldwide. It causes 
many deaths annually ranged between 9% to 10% which is dependent on related risk factors. The main 
pathogenesis has not been determined yet; however, it has been shown, that increased lipid profiles and their 
oxidation in patients can cause endothelial cell dysfunction and thrombosis. Therefore, here we investigated the 
oxidized phospholipids (OxPLs) role in the pathogenesis of coronary artery disease. 
Methods: This cross-sectional study was performed in Shariati Hospital, Tehran. Accordingly, patients with 
coronary artery angiography indications (n=360) were included and classified into one of the following three 
groups, based on the angiographic results: 1) normal coronary artery (not dysfunction in vessels) or mild CAD 
(only intimal irregularity or less than 3% narrowing without ectasia); 2) vessel dilation more than 1.5 times 
compared to the normal part of the vessel or compared to the normal size according to age and gender in one or 
more coronary vessels; and  3) patients with more than 50% stenosis in one of the coronary arteries. The 
peripheral blood was collected from patients in EDTA anticoagulants container tubes and the OxPL level was 
measured using an ELISA kit.  
Results: The results showed that the amount of OxPL in the third and second groups was higher than in the first 
group. It was also found that hyperlipidemia, diabetes, hypertension, and smoking were higher in the third and 
second groups; all mentioned findings were statistically significant (p-value <0.05). 
Conclusion: According to the findings of this study, it was shown that an increase in OxPL in patients with 
coronary ectasia can be considered as a risk factor for disease progression; OxPL measurement can be used to 
identify high-risk individuals. 
Keywords: Coronary Ectasia; Risk Factor; Oxidative Phospholipid; Angiography. 
*Corresponding Author: Seyed Abdolhussein Tabatabaei; Email: tabatabaeiseyedah@gmail.com; ORCID iD: 
0000-0001-5091-6066 
Please cite this article as: Nikdoust F, Lashkari Zadeh F, Tabatabaei SA. Evaluation of OxPL Levels in Patients 




Coronary ectasia is a cardiovascular disease (CVD) 
characterized by endothelial cell (EC) dysfunction 
(1). Due to the increasing prevalence of CVD and 
related mortality, identification of the risk factors 
and effective elements in their pathogenesis is an 
important matter (2, 3). Today, many factors have 
been identified to the pathogenesis of coronary 
ectasia; however, the main factor involved in the 
occurrence and progression of the disease has not 
been identified (4, 5).  
Inflammation is one of the factors influencing CVD 
development, especially coronary ectasia (6, 7). 
According to the inflammation role, it has been 
found that immune system cells and platelets, due 
to inflammatory mediators secretion and 
stimulating the immune response, lead to immune 
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system cells movement towards ECs; it impairs ECs 
function (8, 9). 
 Oxidized phospholipids (OxPLs) play an important 
role in the pathogenesis of coronary ectasia as pro-
inflammatory factors (10). Therefore, it has been 
shown that increased lipid factors and inflammation 
in patients with coronary ectasia lead to increased 
OxPLs serum levels (11-13). Hence, we decided to 
evaluate the relationship between OxPLs levels and 
patients' clinical symptoms in the present study. 
Methods 
This cross-sectional study was approved by the 
Ethics Committee of the Vice Chancellor for 
Research of Tehran University of Medical Science 
(IR.TUMS.THC.REC.1399.058). It was performed 
on patients with Coronary Ectasia referred to 
Shariati Hospital in Tehran, Iran during 2018-2020. 
 The study population included patients, who were 
candidates for coronary angiography. Inclusion 
criteria were as follows: patients with complete case 
information and without any underlying diseases, 
using drugs such as calcium channel blockers, 
angiotensin-converting enzyme inhibitors, aspirin, 
and anti-lipids. Exclusion criteria were patients with 
incomplete case information and the presence of 
underlying disease. In this study, patients were 
classified into one of the following three groups, 
based on the angiographic results: 1) normal 
coronary artery (not dysfunction in vessels)  and 
mild CAD (only intimal irregularity or less than 3% 
narrowing without ectasia); 2) vessel dilation more 
than 1.5 times compared to the normal part of the 
vessel or compared to the normal size according to 
age and gender in one or more coronary vessels; 3) 
patients with stenosis of more than 50% in one of 
the coronary arteries. 
Background information such as age, gender, body 
mass index, information about clinical records, and 
cardiovascular risk factors were all collected 
through interviews or reviewing patients' archives. 
Before angiography, blood samples were taken and 
OxPL levels in apoB-100 lipoprotein were 
evaluated using E06 monoclonal antibody and 
ELISA (Roche, Germany). In the next step, patients 
were classified based on the coronary angiography 
results into one of the mentioned groups. 
Statistical Analysis 
For quantitative variables, mean or median, and 
standard deviation or interquartile range were used 
to describe variable distributions. Frequency and 
percentage were used for qualitative variables. 
Normal distribution was checked using the 
Kolmogorov-Smirnov test. Independent t-test and 
Mann-Whitney U test were used for univariate data 
analysis. The significance level was considered 
0.05. All analyzes were performed using SPSS 
software version 22. 
Results 
In this study, after assessing 360 patients, 120 
patients were evaluated in each group. Clinical and 
demographic information of patients has been listed 
in Table 1. 
As shown in table 1, there were no significant 
differences between patients' ages in all three 
groups. Also, there were no significant differences 
in terms of BMI and systolic and diastolic blood 
pressure between the patients in the three groups. 
The percent of diseases such as diabetes, 
hyperlipidemia, and also smoking was statistically 
higher in the third group compared to the other two 
groups (p-value <0.05). 
Evaluation of OxPL and Lipid profiles in three 
groups 
The results showed that the amount of HDL in the 
first group was higher, but this difference was not 
statistically significant (p-value: 0.24). On the other 
hand, it was found that LDL, Total cholesterol, and 
OxPL levels were higher in the third group, which 
was statistically significant (p-values <0.05) (Table 
2).  
Association between OxPL level and disease 
severity 
Based on the results, OxPL levels were higher in 
the third and second groups compared to the first 
group of patients with a history of diabetes mellitus, 
which was statistically significant (p-value: 0.02). 
On the other hand, it was found that the OxPL level 
was higher in the third group of patients with a 
history of smoking and hyperlipidemia compared to 
the other two groups (p-value <0.05). The OxPL 
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level was the same in the second and the third 
groups of patients with the hypertension history, 
and it was higher than the first group; it was also 
statistically significant (p-value <0.05) (Table 3). 
 
Table 1. Demographic and clinical information of patients (n=360). 
*P-value calculated by T-test or Chi-Square. 
 
Table 2. Levels of OxPL and Lipid profiles in the studied groups (n=360). 
P-value* Group I (n=120) Group II (n=120) Group III (n=120) Variables 
0.24 56.9±18.2 54.9±15.2 59.2±16.2 HDL (mg/dL) 
0.007 161.3±36.5 155.8±39.5 143.8±37.5 LDL (mg/dL) 
0.013 245.6±42.1 240.7±43.8 228.4±42.0 Total Cholesterol (mg/dL) 
0.01 0.9 0.5 0.3 OxPL 
Abbreviations: HDL: High-density lipoprotein; LDL: low-density lipoprotein, OxPL: Oxidized Phospholipids. 
*P-value calculated by ANOVA. 
 
Table 3. Level OxPL in three groups according to smoking and conditions of diseases 
P-value* Group III (n=120) Group II (n=120) Group I (n=120) Variables 
0.02 
0.08 0.4 0.3 Yes 
Diabetes Mellitus (%) 
0.4 0.2 0.2 No 
0.04 
0.7 0.4 0.2 Yes 
Smoking (%) 
0.3 0.2 0.04 No 
0.01 
0.9 0.6 0.4 Yes 
Hyperlipidemia (%) 
0.4 0.3 0.1 No 
0.01 
0.5 0.3 0.2 Yes 
Hypertension (%) 
0.09 0.1 0.01 No 
*P-value calculated by ANOVA. 
 
Discussion 
Coronary artery disease and coronary ectasia are the 
most common vascular diseases in which the main 
arteries that carry blood, oxygen, and nutrients to 
the heart become clogged due to the deposition of 
plaques containing fat, cholesterol, calcium, and 
Variables Group I (n=120) Group II (n=120) Group III (n=120) P-value* 
Age (year) 60.0 ± 10.9 59.6 ± 11.1 60.6 ± 10.7 0.1 
Gender (Male/Female %) 24.2/75.8 62/38 76.4/23.6 0.01 
BMI (Kg/m2) 27.1±3.6 27.1±4.2 29.5±4.8 0.3 
Hypertension 66 74 94.2 0.02 
Diabetes Mellitus (%) 
Yes 42.4 46 59.4 
0.04 
No 57.6 54 40.6 
Smoking (%) 
Yes 15.2 37 43.4 
0.01 
No 84.8 63 56.6 
Hyperlipidemia (%) 
Yes 54.4 60 89 
0.03 
No 45.6 40 11 
Systolic blood pressure (mmHg) 147.4 ±20.3 149.3 ±20.4 152.3 ±22.4 0.3 
Diastolic blood pressure (mmHg) 86.9 ±9.3 87.0 ±9.3 87.1 ±9.5 0.1 
Evaluation of OxPL Levels in Patients Undergoing Coronary …                                                             Masaeli A, et al. 
Archives of Medical Laboratory Sciences; Volume 7, 2021 (Continuous Volume)  4 
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License 
other substances in the blood. Lack of blood supply 
and adequate oxygen for the heart leads to 
myocardial infarction and even death (9, 14).  
Coronary artery diseases have well-known risk 
factors, such as hyperlipidemia, hypertension, 
diabetes mellitus, obesity, poor diet, and smoking 
(2, 15). In addition to the changing dietary patterns 
of individuals in the last decade, new risk factors 
such as oxidative stress and their relationship with 
the incidence of cardiovascular disease have been 
studied. With the aim of treatment and prevention, 
studies have examined several mechanisms for 
rooting out the disease; oxidative stress is one of the 
most important mechanisms (6, 16).  
Recent studies have shown, that lipid profiles and 
oxidative stress are closely related. Based on this, it 
has been found that oxidative stress increment can 
increase the oxidation of fats and phospholipids; it 
leads to the production of oxidized products such as 
OxPL and ox-LDL (16-18). However, few studies 
have been performed on the role of these agents, 
especially OxPL in the pathogenesis of coronary 
ectasia. Therefore, in this study, we aimed to 
evaluate the relationship of OxPL with the 
pathogenesis of coronary artery ectasia. 
The results of the present study showed, that OxPL 
in patients with stenosis of more than 50% in one of 
the coronary arteries, and patients with coronary 
vessel dilation, was significantly higher than 
patients with normal vessels or mild CAD. 
In 2017, Kamstrup et al. conducted a study to 
evaluate the association of OxPL with 
cardiovascular disease in patients with coronary 
heart disease and healthy individuals. The results 
showed a significant correlation between 
apolipoprotein (a) and OxPL-apoB markers. OxPL-
apoB levels were significantly associated with 
coronary heart disease risk factors. A simultaneous 
increase in the serum levels of OxPL-apoB and 
apolipoprotein (a) also doubles the risk of coronary 
heart disease (19). 
 In another study by Tsimikas et al., serum levels of 
OxPL bound to apolipoprotein B-100 or OxPL / 
apoB, as well as Lp (a), were assessed in patients 
undergoing coronary angiography. Moreover, IL-1 
genotypes were also examined. Among patients 
with IL-1 (+), the highest OxPL/apoB quartile was 
associated with an increased risk of coronary heart 
disease-related to its lowest quartile. This effect was 
relatively more severe in patients under the age of 
60. In patients with IL-1 (-), OxPL/apoB had no 
significant correlation with the coronary heart 
disease risk. In IL-1 (+) patients, the median 
OxPL/apoB was also a predictor of four-year 
cardiac-free survival in patients with coronary heart 
disease (20, 21).  
In another study, which evaluated patients with 
sudden cardiac death due to coronary artery 
occlusion and successfully treated patients with 
PCI, serum OxPL / apoB level was assessed before 
and up to one week after the PCI treatment. First, 
the coronary artery IHC technique showed high 
levels of OxPL and MDA-shaped epitopes, 
especially in the recanalized region and organized 
thrombosis. Following PCI, serum levels of OxPL / 
apoB and Lp (a) gradually increased and reached 
the maximum level after 7 days. In contrast, OxPL / 
apoB and Lp (a) increased immediately after PCI in 
the non-involved vessels but returned to the 
baseline rapidly within 24 hours (22).  
The previous history of several diseases is another 
risk factor for disease progression in patients with 
coronary heart disease and ectasia. A study by 
Tsimikas et al. showed that people with a history of 
hyperlipidemia, as well as higher lipid profiles, 
including LDL and triglycerides, had increased 
OxPL levels.  
Finally, it was concluded that lipid profiles 
increment, as a risk factor, increases the OxPL in 
patients; it ultimately leads to disease progression 
and endothelial cell dysfunction (22). In the study 
of Kiechl et al., it was found that previous history of 
diabetes, hypertension, smoking, and 
hyperlipidemia in patients can increase the coronary 
artery disease progression in patients with coronary 
ectasia (23). 
Conclusion 
According to the findings of this study, it was 
shown that an increase in OxPL in patients with 
coronary ectasia can be considered as a risk factor 
for disease progression; OxPL measurement can be 
used to identify high-risk individuals. 
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